A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP)

Journal of Substance Abuse Treatment

Volumn 14, Issue 5, 1997, Pages 445-455

  French, Michael T ^a   Dunlap, Laura J ^b   Zarkin, Gary A ^b   McGeary, Kerry Anne ^a   McLellan, A Thomas ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Economic evaluation; Methods; Treatment cost

Indexed keywords

ARTICLE; DRUG DEPENDENCE TREATMENT; FINANCE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SERVICE; PRIORITY JOURNAL;

COSTS AND COST ANALYSIS; DATA COLLECTION; DRUG COSTS; FINANCING, ORGANIZED; HEALTH CARE COSTS; HEALTH CARE RATIONING; HUMANS; METHADONE; PROGRAM EVALUATION; SOFTWARE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0031466428     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(97)00132-3     Document Type: Article

References (47)

1. Annis, H.M. (1986). Is inpatient rehabilitation of the alcoholic cost-effective? Con position. In Controversies in alcoholism and sub-stance abuse (pp. 175-190). New York: The Haworth Press.
2. Boyle, M.H., Torrance. G.W., Sinclair, J.C., & Horwood, S.P. (1983). Economic evaluation of neonatal intensive care of very low birth-weight infants. New England Journal of Medicine, 308, 1330-1337.
3. Bradley, C.J., French, M.T., & Rachal, J.V. (1994). Financing and cost of standard and enhanced methadone treatment. Journal of Substance Abuse Treatment, 2, 433-442.
4. Bray, J.W., French, M.T., Bowland, B.J., & Dunlap, L.J. (1996). The cost of employee assistance programs (EAPs): Findings from seven case studies. Employee Assistance Quarterly. 11(4), 1-19.
5. California Drug and Alcohol Treatment Assessment (CALDATA). (1994). General report. Sacramento, CA: State of California, Department of Alcohol and Drug Program.
6. Cruze, A., Harwood, H., Kristiansen, P., Collins, J., & Jones, D. (1981). Economic costs of alcohol and drug abuse and mental illness - 1977. Research Triangle Park, NC: Research Triangle Institute.
7. Dennis, ML., Karuntzos, G., McDougal, G., French, M.T., & Hubbard, R. (1993). Developing training and employment programs to meet the needs of methadone treatment clients. Evaluation and Program Planning, 16, 73-86.
8. Dennis, M.L., Fairbank, J.A., Caddell, J.M., Bonito, A.J., Rourke, K.M., Woods, M.G., Rachal, J.V. Bossert, K., & Burke, M. (1995). Individualized substance abuse counseling (ISAC) manual. Blomington, IL: Lighthouse Publications.
9. Drummond, M.F. (1980). Principles of economic appraisal in health care. New York: Oxford University Press.
10. Drummond, G.W., Stoddart, G.L., & Torrance, G.W. (1987). Methods for the economic evaluation of health programmes. Oxford, England: Oxford University Press.
11. Dunlap, L.J., & French, M.T. (in press). A comparison of two methods for estimating the costs of drug abuse treatment. Journal of Maintenance in the Addictions.
12. Eisenberg, J.M. (1989). Clinical economics: A guide to the economic analysis of clinical practices. Journal of the American Medical Association, 262, 2879-2886.
13. Finigan, M. (1996). Societal outcomes and cost savings of drug and alcohol treatment in the state of Oregon. Report prepared for Office of Alcohol and Drug Abuse Programs, Oregon Department of Human Resources, Salem, OR.
14. French, M.T., Bradley, C.J., & Zarkin, G.A. (1992). Drug abuse treatment cost analysis program (DATCAP): Cost interview guide for provider sites. Drug abuse treatment module. Version 1. Research Triangle Park, NC: Research Triangle Institute.
15. French, M.T., Dennis, M.L., McDougal, G.L., Karuntzos, G.T., & Hubbard, R.L. (1992). Training and employment programs in methadone treatment: Client needs and desires. Journal of Substance Abuse Treatment, 9(12), 293-303.
16. French, M.T., Bradley, C.J., Calingaert, B., Dennis, M.L., & Karuntzos, G.T. (1994). Cost analysis of training and employment services in methadone treatment. Evaluation and Program Planning, 17, 107-120.
17. French, M.T., Dunlap, L.D., Zarkin, G.A., & Galinis, D.A. (1994a). Drug abuse treatment cost analysis program (DATCAP): Cost interview guide for provider sites. Drug abuse treatment module. Version 2. Research Triangle Park, NC: Research Triangle Institute.
18. French, M.T., Dunlap, L.D., Zarkin, G.A., & Galinis, D.A. (1994b). Drug abuse treatment financing analysis program (DATFin): Financing interview guide for provider sites. Drug abuse treatment module. Version 1. Research Triangle Park, NC: Research Triangle Institute.
19. French, M.T., Dunlap, L.J., Galinis, D.N., Zarkin, G.A., & Rachal, J.V. (1995). The impact of health care reforms and managed care on the availability, financing, and costs of substance abuse treatment. (Final report prepared for the National Institute on Drug Abuse, 271-912004). Research Triangle Park, NC: Research Triangle Institute.
20. French. M.T. (1995). Economic evaluation of drug abuse treatment programs: Methodology and findings. American Journal of Drug and Alcohol Abuse, 21, 111-135.
21. French. M.T., McGeary, K.A., & McLellan, A.T. (1996a). User's manual for the drug abuse treatment cost analysis program (DATCAP). Version 1. Coral Gables, FL: University of Miami.
22. French, M.T., McGeary, K.A., & McLellan, A.T. (1996b). Drug abuse treatment cost analysis program (DATCAP): Cost interview guide for provider sites. Drug abuse treatment module. Version 3. Coral Gables, FL: University of Miami.
23. French, M.T., McGeary, K.A., & McLellan, A.T. (1996c). Drug abuse treatment financing analysis program (DATFin): Financing interview guide for provider sites. Drug abuse treatment module. Version 2. Coral Gables, FL: University of Miami.
24. French, M.T., Dunlap, L.J., Galinis, D.N., Rachal, J.V., & Zarkin, G.A. (1996). Health care reforms and managed care for substance abuse services: Findings from 11 case studies. Journal of Public Health Policy, 17, 181-203.
25. Gold, M.R., Siegel, J.E., Russell. L.B., & Weinstein, M.C. (eds). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
26. Holder, H.D., & Blose, J.O. (1991). Typical patterns and cost of alcoholism treatment across a variety of populations and providers. Alcoholism: Clinical and Experimental Research, 15, 190-195.
27. Horngren, C.T. (1982). Cost accounting: A managerial emphasis (5th ed.). Englewood Cliffs, NJ: Prentice Hall.
28. Harwood, H.J., Napolitano, D.M., Kristiansen. P.L., & Collins, J.J. (1984). Economic costs to society-of alcohol and drug abuse and mental illness. 1980. (Final report prepared for the Alcohol, Drug Abuse, and Mental Health Administration, RTI 2734/00-01FR). Research Triangle Park, NC: Research Triangle Institute.
29. Horgan, C. (1991). Cost of drug treatment programs: Preliminary findings from the 1990 drug services research survey. (Presented at the NIDA National Conference on Drug Abuse Research and Practice) Washington, DC.
30. Hu, T., McDonnell, N.S., & Swisher, J. (1981). The application of cost-effectiveness analysis to the evaluation of drug abuse prevention programs. An illustration. Journal of Drug Issues, 11, 125-138.
31. Levin, H.M. (1975). Cost-effectiveness analysis in evaluation research. In M. Guttentag & E. Struening (Eds.) Handbook of evaluation research (Vol. 2, pp. 89-122). Beverly Hills, CA: Sage Publishing.
32. Lowson, K.V., Drummond, M.F., & Bishop, J.M. (1981). Costing new services: Long-term domiciliary oxygen therapy. Lancet, ii, 1146-1149.
33. McCrady, B., Longabaugh. R., Fink, E., Stout, R., Beattie, M., & Ruggieri-Authelet, A. (1986). Cost effectiveness of alcoholism treatment in partial hospital versus inpatient settings after brief inpatient treatment: 12-month outcomes. Journal of Consulting and Clinical Psychology. 54, 708-713.
34. McLellan, A.T., Woody, O.E., Luborsky. L., O'Brien, C.P., & Druley, K. A. (1983). Increased effectiveness of substance abuse treatment: A prospective study of patient-treatment matching. Journal of Nervous and Mental Disorders. 171, 597-605.
35. McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody. G.E., O'Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 953-1959.
36. Mishan, E.J. (1975). Cost-benefit analysis. London: George Allen and Unwin.
37. National Institute on Drug Abuse (NIDA). (1987). National drug and alcoholism treatment unit survey (NDATUS). Final Report. Publication No. (ADM) 89-1626).
38. Normand, J., Salyards, S.D., & Mahoney, J.J. (1990). An evaluation of preemployment drug testing. Journal of Applied Psychology, 75, 629-639.
39. Rice, D.P., Kelman, S., & Miller, L.S. (1991). Economic costs of drug abuse. In Economic costs, cost-effectiveness, financing, and community-based drug treatment. Research Monograph Series 113. pp. 10-32. Rockville, MD: National Institute on Drug Abuse.
40. Richardson, A.W., & Gafni, A. (1983). Treatment of capital costs in evaluating health care programmes. Cost and Management. 26-30.
41. Rizzo, J.A., Baker, D.I., McAvay, G., & Tinnetti, M.E. (1996). The cost-effectiveness of a multifactorial targeted prevention program for falls among community elderly persons. Medical Care, 34, 954-969.
42. Sloan, F.A. (ed.). (1996). Valuing health care. New York: Cambridge University Press.
43. Sugden, R., & Williams, A.H. (1979). The principles of practical costbenefit analysis. New York: Oxford University Press.
44. Tolley, G., Kenkel, D., & Fabian, R. (1994). Valuing health for policy: An economic approach. Chicago, IL: The University of Chicago Press.
45. Warner, K.E., & Luce, B.R. (1982). Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, MI: Health Administration Press.
46. Weinstein, M.C., & Stason, W.B. (1977). Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 296, 716-721.
47. Zarkin, G.A., Galinis, D.N., French, M.T., Fountain, D.L., Ingram, P.W., & Guyett, J.A. (1995). Financing strategies for drug abuse treatment programs. Journal of Substance Abuse Treatment, 12, 385-399.